{
    "clinical_study": {
        "@rank": "80557", 
        "acronym": "TOMOREP", 
        "arm_group": {
            "arm_group_label": "Radiotherapy", 
            "arm_group_type": "Other", 
            "description": "Evaluation of the combination of radiotherapy with tomotherapy coil (54 Gy) followed by surgery in liposarcomas retroperitoneal."
        }, 
        "brief_summary": {
            "textblock": "Retro peritoneal liposarcomas are rare (less than 15% of sarcomas) whose prognosis is\n      locoregional.\n\n      In the treatment of retroperitoneal liposarcomas main prognostic factor is the quality of\n      the surgical resection. The effect of radiotherapy combined with surgery is uncertain and\n      until now limited perhaps because of limited prescribed doses (of the order of 45Gy to 50Gy)\n      due to high risk of organ toxicity nearby.\n\n      The helical tomotherapy is an innovative equipment radiotherapy to make conformational\n      radiotherapy modulation intensity and is particularly suitable for irradiations precision\n      (imaging mode associated with daily scanner) in large complex volumes. Increasing doses\n      (increase of the prescribed dose to 54 Gy, thus potentially curative), the helical\n      tomotherapy should allow to improve the efficacy of radiotherapy."
        }, 
        "brief_title": "Assessment of Helical Tomotherapy Radiotherapy (54 Gy) Followed by Surgery in Retro-peritoneal Liposarcoma", 
        "completion_date": {
            "#text": "December 2019", 
            "@type": "Anticipated"
        }, 
        "condition": "Liposarcoma", 
        "condition_browse": {
            "mesh_term": [
                "Liposarcoma", 
                "Retroperitoneal Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "Retro peritoneal liposarcomas are rare (less than 15% of sarcomas) whose prognosis is\n      locoregional. In the treatment of retroperitoneal liposarcomas main prognostic factor is the\n      quality of the surgical resection. The effect of radiotherapy combined with surgery is\n      uncertain and until now limited perhaps because of limited prescribed doses (of the order of\n      45Gy to 50Gy) due to high risk of organ toxicity nearby.\n\n      Two elements can overcome these difficulties:\n\n        -  Preoperative radiotherapy made \u200b\u200brather than Postoperatively, the tumor in place back\n           the gastrointestinal tract and reducing toxicity,\n\n        -  The contribution of conformal radiotherapy techniques with intensity modulation (IMRT).\n           The helical tomotherapy is an innovative equipment radiotherapy to make conformational\n           radiotherapy modulation intensity and is particularly suitable for irradiations\n           precision (imaging mode associated with daily scanner) in large complex volumes.\n           Increasing doses (increase of the prescribed dose to 54 Gy, thus potentially curative),\n           the helical tomotherapy should allow to improve the efficacy of radiotherapy."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Liposarcoma histologically proven, in case of non-biopsy contributive: diagnosis\n             radiologically validated meeting multidisciplinary consultation (RCP)\n\n          2. Protocol TOMOREP technically feasible,\n\n          3. Patients over 18 years\n\n          4. Considered a priori tumor operable even with excision multi-visceral\n\n          5. Absence of morbidity against-indicating surgery necessary\n\n          6. Original form (as well as tumors made \u200b\u200bafter first incomplete excision) and form in\n             first relapse.\n\n          7. Life expectancy greater than 6 months\n\n          8. Patient signed informed consent,\n\n          9. Patient affiliated to a social security scheme.\n\n        Exclusion Criteria:\n\n          1. Metastasis associated\n\n          2. Extension intraperitoneal associated mesenteric extension\n\n          3. bilaterally\n\n          4. Against disease-indicating the need for surgery (ASA 3 and 4).\n\n          5. Cons-indication for radiotherapy (such as prior radiotherapy the volume to be\n             treated).\n\n          6. Patient included in another clinical study\n\n          7. Unable to undergo medical monitoring test for geographical, social or psychological,\n\n          8. Private patient freedom and major subject of a measure of legal protection or unable\n             to consent."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "44", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 5, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01841047", 
            "org_study_id": "IB2008-42"
        }, 
        "intervention": {
            "arm_group_label": "Radiotherapy", 
            "description": "Evaluation of the efficacy of the combination with radio-surgery helical tomotherapy irradiation to a dose of radiation of 54 Gy in patients with retroperitoneal liposarcoma of operable", 
            "intervention_name": "Radiotherapy", 
            "intervention_type": "Radiation"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Retroperitoneal liposarcoma operable", 
        "lastchanged_date": "April 23, 2013", 
        "link": {
            "description": "Site internet du promoteur, l'Institut Bergoni\u00e9", 
            "url": "http://www.bergonie.org/fr/essais-clinique.html"
        }, 
        "location": [
            {
                "contact": {
                    "last_name": "NOEL Georges, PU-PH"
                }, 
                "facility": {
                    "address": {
                        "city": "Strasbourg", 
                        "country": "France", 
                        "state": "Alsace", 
                        "zip": "67000"
                    }, 
                    "name": "Centre Paul Strauss"
                }, 
                "investigator": {
                    "last_name": "NOEL Georges, PU-PH", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "g.kantor@bordeaux.unicancer.fr", 
                    "last_name": "KANTOR Guy, PU-PH"
                }, 
                "facility": {
                    "address": {
                        "city": "Bordeaux", 
                        "country": "France", 
                        "state": "Aquitaine", 
                        "zip": "33000"
                    }, 
                    "name": "Institut Bergoni\u00e9"
                }, 
                "investigator": {
                    "last_name": "KANTOR Guy, PU-PH", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "ALAPETITE Claire, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "state": "Ile de France", 
                        "zip": "75000"
                    }, 
                    "name": "Institut Curie"
                }, 
                "investigator": {
                    "last_name": "ALAPETITE Claire, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "DELANNES Martine, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Toulouse", 
                        "country": "France", 
                        "state": "Midi-Pyr\u00e9n\u00e9es", 
                        "zip": "31000"
                    }, 
                    "name": "Centre Claudius Regaud"
                }, 
                "investigator": {
                    "last_name": "DELANNES Martine, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "MAHE Marc Andr\u00e9, PU-PH"
                }, 
                "facility": {
                    "address": {
                        "city": "Nantes", 
                        "country": "France", 
                        "state": "Pays de la Loire", 
                        "zip": "44000"
                    }, 
                    "name": "Centre Ren\u00e9 Gauducheau"
                }, 
                "investigator": {
                    "last_name": "MAHE Marc Andr\u00e9, PU-PH", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Assessment of Helical Tomotherapy Radiotherapy (54 Gy) Followed by Surgery in Retro-peritoneal Liposarcoma", 
        "overall_contact": {
            "email": "g.kantor@bordeaux.unicancer.fr", 
            "last_name": "KANTOR Guy, PU-PH"
        }, 
        "overall_contact_backup": {
            "email": "s.mathoulin@bordeaux.unicancer.fr", 
            "last_name": "MATHOULIN PELISSIER Simone, PU-PH"
        }, 
        "overall_official": {
            "affiliation": "Institut Bergoni\u00e9", 
            "last_name": "KANTOR Guy, PU-PH", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "August 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Evaluation of the efficacy of the combination with radio-surgery helical tomotherapy irradiation to a dose of radiation of 54 Gy in patients with retroperitoneal liposarcoma of operable. The effectiveness will be evaluated in terms of disease-free survival Local 3 years", 
            "measure": "disease-free survival Evaluation of the efficacy of the combination with radio-surgery helical tomotherapy irradiation to a dose of radiation of 54 Gy in patients with retroperitoneal liposarcoma of operable.", 
            "safety_issue": "No", 
            "time_frame": "08/2013 (3 years)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01841047"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Evaluation of the toxicity of the combination radio-surgical\nAssessment of local recurrence-free survival at 1 year and 5 years\nEvaluation of overall survival at 1, 3 and 5 years,\nDescription of the technical feasibility of the association radiosurgery, in terms of compliance with the prescribed dose of dose constraints modulated conformal radiotherapy intensity", 
            "measure": "Evaluation of the toxicity of the combination radio-surgical", 
            "safety_issue": "No", 
            "time_frame": "08/2013 (1, 3, 5 years)"
        }, 
        "source": "Institut Bergoni\u00e9", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Institut Bergoni\u00e9", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2009", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}